Vicarious Surgical Q2 2022: adjusted net loss $19.1M, operating expenses up 189% YoY

Vicarious Surgical Inc.

2022-Q2 EPS reported $0.32

Operating expenses of $19.1M for Q2 2022, up from $6.6M in Q2 2021; R&D $10.1M, G&A $7.8M, S&M $1.3M.
Adjusted net loss of $19.1M ($0.16 loss per share) vs $6.6M ($0.08 loss per share) prior year.
GAAP net loss of $1.5M ($0.01 loss per share) vs $6.6M ($0.08 loss per share) prior year.
Cash burn rate for Q2 2022 was $15.7M; no revenue reported (pre-commercial stage).
Beta 2 system development ongoing; announced Center of Excellence partnerships with UH Ventures and HCA Healthcare.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.